The Commissioner of Income-tax (Appeals) has upheld a penalty of Rs. 96,86,205 against chambal fertilisers & chemicals , rejecting the company's appeal against an original assessment order dated March 9, 2026. The penalty, levied under Section 271(1)(c) of the Income Tax Act, 1961, stems from the disallowance of provisions for loss or diminution in value of investments and expenses incurred on the construction of an anicut. Chambal Fertilisers received the Order-in-Appeal on August 7, 2026, confirming the financial liability previously flagged in March.

Regulatory Disclosure

The company disclosed the development pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR). This update follows an earlier communication issued under reference number CFCL/SE/2025-26/84 on March 10, 2026, which notified investors of the initial penalty imposed by the Assessment Unit of the Income Tax Department. The current filing confirms that the appellate authority did not overturn the original finding.

Nature of Dispute

The core of the dispute involves specific accounting treatments rejected by the tax authorities. The penalty was triggered by the disallowance of two key items: provisions made for the loss or diminution in value of investments, and capital expenditures incurred for the construction of an anicut. The appellate order maintains that these deductions were not permissible under the relevant sections of the Income Tax Act, thereby sustaining the monetary penalty levied in the original assessment.

Company Response and Next Steps

Chambal Fertilisers stated that the penalty has no impact on its financial, operational, or other activities beyond the immediate monetary liability of Rs. 96,86,205. Management indicated that the company holds a strong case on merits regarding the disputed provisions. Consequently, Chambal Fertilisers plans to challenge the Order-in-Appeal before the appropriate higher authority. The disclosure was signed by Tridib Barat, Vice President - Legal & Company Secretary, on August 7, 2026.

Chambal Fertilisers & Chemicals Limited reported a 12% year-on-year increase in standalone EBITDA to ₹850.9 crore for the quarter ended June 30, 2026 (Q1FY27), driven by significant margin expansion that offset a decline in top-line revenue. Standalone net profit after tax (PAT) rose 10% to ₹703.5 crore, while consolidated PAT declined 5% to ₹523.6 crore, primarily due to losses from its joint venture, Indo Maroc Phosphore S.A. (IMACID). The company’s standalone EBITDA margin improved to 16.93% from 13.36% in Q1FY26, demonstrating strong operational efficiency despite a 12% drop in operating income to ₹5,027 crore.

The unaudited financial results were filed with the stock exchanges under Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. An earnings call held on July 31, 2026, provided further details on segment performance and strategic initiatives. Managing Director Abhay Baijal and CFO Anuj Jain highlighted that margin improvement was supported by cost efficiencies and favorable mix shifts in Crop Protection Chemicals (CPC) and Speciality Nutrients (SN). However, urea volumes remained lower than expected due to planned shutdowns at the Gadepan plants.

Financial Performance

Standalone operational income fell to ₹5,027 crore from ₹5,698 crore in Q1FY26, primarily due to lower urea volumes. Despite this, expenses decreased by 15% to ₹4,176 crore, contributing to the EBITDA growth. Consolidated figures show a similar trend, with EBITDA rising 12% to ₹850.8 crore. The decline in consolidated PAT was largely attributed to a ₹25.1 crore loss from IMACID, compared to a ₹36.1 crore profit in the same period last year. IMACID resumed production in July 2026 after a prolonged shutdown caused by sulfur shortages and high prices.

Operational Updates

Chambal Fertilisers is advancing its new urea plant project under the National Investment Policy for Urea-2026 (NIPU2026). Site enabling activities, including fencing and geo-technical studies, are complete, and environmental clearance is in progress. The company has received in-principle approval from gas suppliers and expects technical bid submissions from LSTK/EPC bidders shortly. Post-completion, CFCL aims to become the largest single-location urea producer in India.

In the biologicals segment, the company launched "Uttam Superrhiza" and "Uttam Pranaam," covering 3 million acres. It also introduced seven new CPC products and two seed varieties (Maize and Bajra). The joint venture with TERI, the CFCL-TERI Centre of Excellence, is developing 10 novel products, with five slated for launch in FY28-29.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the volatility of the joint venture segment. While core operations delivered robust margin expansion (EBITDA margin up 3.57 percentage points), the IMACID loss dragged down overall group profitability. This underscores the company’s strategic focus on reducing dependency on volatile raw material markets through vertical integration and domestic capacity expansion. The near-zero net debt-to-equity ratio of 0.01% as of FY26 provides a strong balance sheet foundation for future capital expenditures.